[1] [1] SCHREUDERS E H, RUCO A, RABENECK L, et al. Colorectal cancer screening: a global overview of existing programmes ［J］. Gut, 2015, 64(10): 1637-1649.

[2] [2] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA: A Cancer Journal for Clinicians, 2018, 68(6): 394-424.

[3] [3] ARNOLD M, SIERRA M S, LAVERSANNE M, et al. Global patterns and trends in colorectal cancer incidence and mortality ［J］. Gut, 2017, 66(4): 683-691.

[5] [5] GILES R H, VAN ES J H, CLEVERS H. Caught up in a Wnt storm: Wnt signaling in cancer ［J］. Biochimica et Biophysica Acta, 2003, 1653(1): 1-24.

[6] [6] CHANG G J, RODRIGUEZ-BIGAS M A, SKIBBER J M, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review ［J］. Journal of the National Cancer Institute, 2007, 99(6): 433-441.

[7] [7] ARKENAU H T, ARNOLD D, CASSIDY J, et al. Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials ［J］. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2008, 26(36): 5910-5917.

[8] [8] ROSSO MPO, BUCHAIM D V, POMINI K T, et al. Photobiomodulation therapy (pbmt) applied in bone reconstructive surgery using bovine bone grafts: a systematic review ［J］. Materials (Basel, Switzerland), 2019, 12(24): 1-17

[11] [11] BERG K C, EIDE P W, EILERTSEN I A, et al. Multi-omics of 34 colorectal cancer cell lines-a resource for biomedical studies ［J］. Molecular Cancer, 2017, 16(1): 116.

[12] [12] MARKOWITZ S D, BERTAGNOLLI M M. Molecular origins of cancer: molecular basis of colorectal cancer ［J］. The New England Journal of Medicine, 2009, 361(25): 2449-2460.

[13] [13] DOW L E, O’ROURKE K P, SIMON J, et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer ［J］. Cell, 2015, 161(7): 1539-1552.

[14] [14] NUSSE R, CLEVERS H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities ［J］. Cell, 2017, 169(6): 985-999.

[15] [15] CHENG X, XU X, CHEN D, et al. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer ［J］. Biomed Pharmacother, 2019, 110: 473-481.

[16] [16] LIU C, LI Y, SEMENOV M, et al. Control of beta-catenin phosphorylation/degradation by a dualkinase mechanism［J］. Cell, 2002, 108: 837-847.

[17] [17] LI Q, LI C, XI S, et al. The effects of photobiomodulation therapy on mouse pre-osteoblast cell line MC3T3-E1 proliferation and apoptosis via miR-503/Wnt3a pathway ［J］. Lasers in Medical Science, 2019, 34(3): 607-614.

[18] [18] HENDERSON B R, FAGOTTO F. The ins and outs of APC and beta-catenin nuclear transport ［J］. EMBO Reports, 2002, 3(9): 834-839.

[19] [19] HENDERSON B R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover ［J］. Nature Cell Biology, 2000, 2(9): 653-660.

[20] [20] WU S, XING D, GAO X, et al. High fluence low-power laser irradiation induces mitochondrial permeability transition mediated by reactive oxygen species ［J］. Journal of Cellular Physiology, 2009, 218(3): 603-611.

[21] [21] SCHARTINGER V H, GALVAN O, RIECHELMANN H, et al. Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy ［J］. Supportive Care in Cancer:Official Journal of the Multinational Association of Supportive Care in Cancer, 2012, 20(3): 523-529.

[22] [22] HUANG Y Y, CHEN A C, CARROLL J D, et al. Biphasic dose response in low level light therapy ［J］. Dose-response: A Publication of International Hormesis Society, 2009, 7(4): 358-383.

[23] [23] HUANG Y Y, SHARMA S K, CARROLL J, et al. Biphasic dose response in low level light therapy - an update ［J］. Dose-response: A Publication of International Hormesis Society, 2011, 9(4): 602-618.

[24] [24] SMALLEY K S. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? ［J］. International Journal of Cancer, 2003, 104(5): 527-532.

[25] [25] SHAN B E, WANG M X, LI R Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway ［J］. Cancer Investigation, 2009, 27(6): 604-612.